enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Eli Lilly: Positive results on its new Alzheimer's drug - AOL

   www.aol.com/finance/eli-lilly-positive-results...

   Eli Lilly reported positive results for its Alzheimer's drug, donanemab, and plans to file for approval with the FDA by the end of the quarter.The drug slowed clinical decline by 35% in the ...

3. Eli Lilly Alzheimer's drug approved by US FDA - AOL

   www.aol.com/news/us-fda-approves-lillys...

   (Reuters) -The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second therapy for slowing progression of the brain-wasting disease ...

4. FDA approves Eli Lilly’s Alzheimer’s drug Kisunla - AOL

   www.aol.com/news/fda-approves-eli-lilly...

   The Food and Drug Administration approved a new Alzheimer’s drug from Eli Lilly that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities in people with ...

5. FDA approves donanemab, Eli Lilly’s treatment for early ...

   www.aol.com/fda-approves-donanemab-eli-lilly...

   Donanemab, made by Indianapolis-based Eli Lilly, works by helping the body remove amyloid plaque buildup in the brain, a hallmark of Alzheimer’s disease. Lilly said it will be sold under the ...

6. Eli Lilly's Alzheimer's Drug Raises Hopes but Faces ... - AOL

   www.aol.com/eli-lillys-alzheimers-drug-raises...

   Amid the excitement around new investments, scrutiny continues over Lilly's Alzheimer's drug, donanemab. David Ricks, CEO of Eli Lilly, has touted the drug's potential as a groundbreaking ...

7. Solanezumab - Wikipedia

   en.wikipedia.org/wiki/Solanezumab

   Solanezumab (proposed INN, LY2062430 [1]) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector [2] for patients with Alzheimer's disease. [3] [4] The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials. [5] [6]